Traditional Chinese medicine for antipsychotic-induced hyperprolactinemia: A comprehensive review… — Journal of ethnopharmacology (2026)
This content is not available in your language yet.
Resumo clínico (PT)
Seção intitulada “Resumo clínico (PT)”Pendente.
Abstract (original)
Seção intitulada “Abstract (original)”Traditional Chinese medicine (TCM) has long employed herbal formulas for conditions manifesting as menstrual irregularities, galactorrhea, and infertility-symptom constellations overlapping with hyperprolactinemia (HPRL). Classical formulas such as Peony-Glycyrrhiza Decoction, documented for “liver constraint” patterns associated with amenorrhea, provide an ethnopharmacological rationale for investigating their relevance to antipsychotic-induced HPRL through modern mechanistic studies and network pharmacology. This review critically evaluates the scientific evidence supporting TCM interventions for antipsychotic-induced HPRL, elucidating multi-target mechanisms via network pharmacology and experimental data, thereby linking traditional uses with pharmacological validation. This narrative review synthesizes literature from PubMed, CNKI, TCMSP, and HERB databases (January 2000-December 2024) on TCM interventions for antipsychotic-induced HPRL. Network pharmacology analyses, molecular docking studies, experimental validations, and clinical studies of individual herbs and complex formulas were critically evaluated. TCM ameliorates HPRL through multi-dimensional mechanisms: dopaminergic modulation via DRD2 upregulation and MAO inhibition; epigenetic regulation through DNMT inhibition and DRD2 promoter demethylation; restoration of the gut-brain-pituitary axis via microbiota modulation and anti-inflammatory effects; and regulation of key signaling pathways (JAK2/STAT5, NF-κB, PI3K/Akt). Network pharmacology reveals convergent pathway enrichment across formulas, including dopaminergic synapse, TGF-β signaling, and neuroactive ligand-receptor interactions. Clinically, Peony-Glycyrrhiza Decoction reduces prolactin by -32.69 ng/mL (p < 0.00001) with favorable safety. TCM represents a promising multi-target approach for antipsychotic-induced HPRL, addressing complex neuroendocrine dysregulation through component synergy. Network pharmacology effectively bridges TCM theory with mechanistic research, supporting evidence-based integration into psychiatric care.